Bruce I. Sachs - Aug 6, 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Aug 6, 2025
Transactions value $
$1,948,416
Form type
4
Date filed
8/7/2025, 04:19 PM
Previous filing
Jul 17, 2025
Next filing
Oct 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SACHS BRUCE I Director C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 2025-08-07 0001197036

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Purchase $636K +1.63K +4.09% $389.36 41.6K Aug 6, 2025 Direct F1, F2
transaction VRTX Common Stock Purchase $1.31M +3.37K +8.08% $389.84 45K Aug 6, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60).
F2 Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00).